MaxCyte Files 2025 Proxy Statement
Ticker: MXCT · Form: DEFA14A · Filed: May 29, 2025 · CIK: 1287098
Sentiment: neutral
Topics: proxy-statement, annual-meeting, governance
TL;DR
MaxCyte's proxy statement is out, vote your shares!
AI Summary
MaxCyte, Inc. filed its Definitive Proxy Statement (DEFA14A) on May 29, 2025, for its 2025 Annual Meeting of Stockholders. The filing details the company's governance and the proposals to be voted on by shareholders. The proxy statement serves to inform stockholders about the meeting and encourage participation in voting.
Why It Matters
This filing is crucial for shareholders as it outlines the company's governance, executive compensation, and any proposed changes or director elections, directly impacting their investment and voting rights.
Risk Assessment
Risk Level: low — This is a routine proxy filing for an annual meeting and does not contain new financial information or significant strategic changes.
Key Players & Entities
- MAXCYTE, INC. (company) — Registrant
- 0001104659-25-054280 (filing_id) — Accession Number
- May 29, 2025 (date) — Filing Date
FAQ
What is the purpose of this DEFA14A filing?
The purpose of this DEFA14A filing is to serve as the Definitive Proxy Statement for MaxCyte, Inc.'s 2025 Annual Meeting of Stockholders, providing shareholders with information to vote on company matters.
When was this filing submitted to the SEC?
This filing was submitted to the SEC on May 29, 2025.
What is the company's Central Index Key (CIK)?
MaxCyte, Inc.'s Central Index Key (CIK) is 0001287098.
Where is MaxCyte, Inc. headquartered?
MaxCyte, Inc.'s business and mail address is 9713 Key West Avenue, Suite 400, Rockville, MD 20850.
What is the SEC file number for MaxCyte, Inc. under the 1934 Act?
MaxCyte, Inc.'s SEC file number is 001-40674.
Filing Details
This Form DEFA14A (Form DEFA14A) was filed with the SEC on May 29, 2025 regarding MAXCYTE, INC. (MXCT).